#1 Clinical Trials Search in Europe

Pimozide

This article examines clinical trials investigating the use of pimozide, an antipsychotic medication, in treating various neurological and psychiatric conditions. The trials explore pimozide’s potential benefits for disorders such as Tourette syndrome, schizophrenia, and post-COVID-19 tinnitus. Researchers are evaluating pimozide’s efficacy, safety, and ability to enhance the effects of other medications in managing symptoms and improving quality of life for patients with these challenging conditions.

Table of Contents

What is Pimozide?

Pimozide is an antipsychotic medication used to treat various mental health conditions. It is also known by the brand name Orap[1]. Pimozide belongs to a class of drugs called dopamine receptor antagonists, which means it works by blocking certain chemical signals in the brain[2].

Uses of Pimozide

Pimozide is primarily used to treat the following conditions:

  • Tourette Syndrome: This is a neurological disorder characterized by repetitive, involuntary movements and vocalizations called tics. Pimozide has been studied for its effectiveness in controlling tics and behavioral symptoms associated with Tourette Syndrome[1].
  • Schizophrenia: Pimozide is used in the treatment of schizophrenia, particularly in cases where patients have not responded well to other antipsychotic medications[2]. Schizophrenia is a serious mental disorder that affects a person’s ability to think, feel, and behave clearly.
  • Treatment-resistant psychosis: In some cases, pimozide is used in combination with other medications like clozapine to treat psychosis that hasn’t responded to other treatments[2]. Psychosis is a condition where a person loses touch with reality, experiencing hallucinations or delusions.
  • Tinnitus: Some research is exploring the use of pimozide in treating tinnitus (ringing in the ears) that occurs after COVID-19 infection[4].

How Pimozide Works

Pimozide works by blocking dopamine receptors in the brain. Dopamine is a neurotransmitter (a chemical messenger) that plays a role in movement, emotion, and thought processes. By blocking these receptors, pimozide can help reduce symptoms of conditions like schizophrenia and Tourette Syndrome[2].

In some cases, pimozide is used to enhance the effects of other medications. For example, it has been studied in combination with clozapine (another antipsychotic medication) to improve its effectiveness in treating schizophrenia[2].

Dosage and Administration

The dosage of pimozide can vary depending on the condition being treated and the individual patient. Here are some general guidelines based on clinical trials:

  • For Tourette Syndrome: Doses may range from 1-10 mg per day, with treatment often starting at lower doses and gradually increasing as needed[1].
  • For schizophrenia: Doses of up to 6 mg per day have been studied[3].
  • For treatment-resistant psychosis: When used in combination with clozapine, doses of 2-8 mg per day have been studied[2].

It’s important to note that pimozide should only be taken under the supervision of a healthcare professional. They will determine the appropriate dosage based on your specific condition and response to the medication.

Side Effects and Safety

Like all medications, pimozide can cause side effects. Some potential side effects include:

  • Movement disorders or involuntary movements
  • Changes in heart rhythm (QT prolongation)
  • Drowsiness or sedation
  • Weight gain
  • Dry mouth
  • Constipation

Pimozide requires careful monitoring, especially for its effects on heart rhythm. Your doctor may perform regular electrocardiograms (ECGs) to check for any changes in your heart’s electrical activity[5].

Ongoing Research

Researchers continue to study pimozide for various conditions:

  • Its effectiveness in treating Tourette Syndrome, particularly in controlling tics and behavioral symptoms[1].
  • Its potential use in combination with other medications like clozapine for treatment-resistant schizophrenia[2].
  • Its possible role in treating tinnitus associated with COVID-19[4].
  • Its effects on neuromuscular junction transmission in conditions like amyotrophic lateral sclerosis (ALS)[6].

These ongoing studies aim to better understand how pimozide works and identify new potential uses for the medication.

Condition Study Design Pimozide Dosage Primary Outcome Measures Duration
Tourette Syndrome Randomized, double-blind Flexible dosing Time to tic exacerbation, tic severity 12 months
Schizophrenia (with Clozapine) Randomized, double-blind 2-8 mg/day PANSS scores, CGI scores 12 weeks
Post-COVID-19 Tinnitus Randomized, double-blind 1 mg/day Tinnitus Handicap Inventory (THI) score Not specified
ALS (Neuromuscular Junction) Randomized, double-blind 6 mg/day ALSFRS-R score, Slow Vital Capacity 22-26 weeks
QT Interval Study Randomized, double-blind 6 mg/day QTc and J-TpeakC interval changes 3 days

FAQ

  • What conditions are being studied with pimozide in these clinical trials? The clinical trials are investigating pimozide for several conditions, including Tourette syndrome, schizophrenia, post-COVID-19 tinnitus, and as a potential treatment for neuromuscular junction transmission dysfunction in amyotrophic lateral sclerosis (ALS).
  • How is pimozide being used in combination with other drugs in some trials? In some trials, pimozide is being studied in combination with other medications. For example, one study is examining pimozide's ability to enhance the effects of clozapine in treating schizophrenia. Another trial is investigating the combination of pimozide with moxifloxacin to understand the effects on heart rhythm (QT interval).
  • What are some of the primary outcomes being measured in these pimozide trials? Primary outcomes vary depending on the condition being studied. They include changes in tic severity for Tourette syndrome, improvements in psychiatric symptoms for schizophrenia (measured by scales like PANSS and CGI), changes in tinnitus severity, and effects on QT interval prolongation in cardiac studies.
  • Are there any potential side effects of pimozide being monitored in these trials? Yes, the trials are monitoring for potential side effects of pimozide. Common areas of concern include movement disorders, changes in heart rhythm (QT prolongation), and other adverse events. Researchers use various scales and assessments to track these potential side effects throughout the studies.
  • How long do these pimozide clinical trials typically last? The duration of the trials varies. Some studies last for a few weeks, while others extend for several months or even up to a year. For example, the Tourette syndrome study follows patients for 12 months, while the schizophrenia trials often last between 12 to 26 weeks.

Ongoing Clinical Trials on Pimozide

  • Study on Continuing or Reducing Antipsychotic Medication (Haloperidol, Clozapine, Tiapride) for Patients After First Episode of Psychosis

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Pimozide: An antipsychotic medication used to treat various neurological and psychiatric conditions. It works by blocking dopamine receptors in the brain.
  • Tourette Syndrome: A neurological disorder characterized by repetitive, involuntary movements and vocalizations called tics.
  • Schizophrenia: A chronic mental disorder that affects a person's thinking, feeling, and behavior, often causing them to lose touch with reality.
  • Tinnitus: The perception of ringing or other noises in one or both ears when no external sound is present.
  • Amyotrophic Lateral Sclerosis (ALS): A progressive nervous system disease that affects nerve cells in the brain and spinal cord, causing loss of muscle control.
  • Neuromuscular Junction: The site where nerve cells connect with muscles, allowing the transmission of signals that cause muscle contraction.
  • QT Interval: A measurement on an electrocardiogram that represents the time it takes for the heart's electrical system to recharge between beats.
  • PANSS (Positive and Negative Syndrome Scale): A medical scale used to measure symptom severity in patients with schizophrenia.
  • CGI (Clinical Global Impression): A rating scale used by healthcare professionals to assess the overall severity and improvement of a patient's condition.
  • Clozapine: An antipsychotic medication used to treat severe schizophrenia that has not responded to other treatments.

References

  1. https://clinicaltrials.gov/study/NCT00004652
  2. https://clinicaltrials.gov/study/NCT00158223
  3. https://clinicaltrials.gov/study/NCT00374244
  4. https://clinicaltrials.gov/study/NCT05507372
  5. https://clinicaltrials.gov/study/NCT05716854
  6. https://clinicaltrials.gov/study/NCT02463825